Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$515.08 - $576.87 $12,877 - $14,421
-25 Reduced 5.92%
397 $214,000
Q4 2023

Jan 31, 2024

SELL
$391.37 - $557.56 $14,872 - $21,187
-38 Reduced 8.26%
422 $234,000
Q2 2023

Jul 13, 2023

SELL
$450.7 - $503.61 $2,253 - $2,518
-5 Reduced 1.08%
460 $231,000
Q1 2023

Apr 20, 2023

BUY
$406.01 - $514.59 $188,794 - $239,284
465 New
465 $232,000
Q2 2022

Jul 19, 2022

SELL
$327.37 - $553.44 $160,411 - $271,185
-490 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$466.52 - $631.01 $6,997 - $9,465
-15 Reduced 2.97%
490 $268,000
Q3 2021

Nov 09, 2021

SELL
$621.9 - $705.76 $307,840 - $349,351
-495 Reduced 49.5%
505 $314,000
Q3 2021

Nov 03, 2021

BUY
$621.9 - $705.76 $621,900 - $705,760
1,000 New
1,000 $212,000
Q2 2021

Jul 16, 2021

SELL
$486.36 - $637.08 $248,043 - $324,910
-510 Closed
0 $0
Q1 2021

Apr 28, 2021

BUY
$465.18 - $551.79 $237,241 - $281,412
510 New
510 $250,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $37.6B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Bender Robert & Associates Portfolio

Follow Bender Robert & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.